LAMASSU PHARMA
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis. Their lead candidate is a novel small molecule therapy for acute pancreatitis. This was developed at Mayo Clinic by leading scientists and has profound preclinical efficacy to completely mitigate mortality and morbidity associated with severe acute pancreatitis. We are currently focused on the continued development of this compound through safety testing in preparation for definitive clinical trials. Our ultimate goal is to save the lives of patients afflicted with this disease.
LAMASSU PHARMA
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.lamassupharma.com
Total Employee:
1+
Status:
Active
Contact:
1-919-667-8571
Email Addresses:
[email protected]
Total Funding:
2.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google
Current Employees Featured
Founder
Official Site Inspections
http://www.lamassupharma.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Lamassu Pharma" on Search Engine
Home | Lamassu Pharma, LLC
Science-Driven, Innovative Solutions to Meet Patient Needs. ABOUT LAMASSU. Accelerating treatment, means saving more lives. At Lamassu, our team of dedicated physicians, engineers, and translational scientists, …See details»
Lamassu Pharma - Crunchbase Company Profile & Funding
Also Known As Lamassu Bio Inc. Legal Name Lamassu Pharma LLC. Company Type For Profit. Contact Email [email protected]. Phone Number 1-919-667-8571. …See details»
Lamassu Pharma Company Profile 2024: Valuation, Funding
Contact Information. site. www.lamassupharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Primary Industry. Drug Discovery. …See details»
Meet another new biotech startup, Lamassu Bio, emerging from …
Mar 17, 2022 Lamassu Bio lamassu pharma. Screenshot of Lamassu Pharma LLC website. by WRAL TechWire — March 17, 2022 . DURHAM – There’s a new …See details»
Gabi Hanna - CEO & Co-Founder at Lamassu Pharma | The Org
Lamassu Pharma. Gabi Hanna. CEO & Co-Founder at Lamassu Pharma. Show contact. Gabi Hanna is an Entrepreneur with long experience in early drug development over 15 …See details»
Lamassu Pharma - Org Chart, Teams, Culture & Jobs | The Org
View Lamassu Pharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Lamassu Awarded NIH Grant For Breakthrough Cancer …
CLEVELAND, March 12, 2024 /PRNewswire/ -- Lamassu Bio Inc., a cutting-edge biotech company dedicated to innovative cancer therapies, has been awarded a grant from the …See details»
Gabi Hanna | Chief Executive Officer and Co-Founder - Lamassu …
Jun 17, 2021 Company details. Lamassu Pharma, LLC. Company bio. Founded in 2018, Lamassu Pharma leverages innovative and insightful technology to drive collaboration …See details»
Lamassu Pharma Receives Prestigious $1.5 Million NIH SBIRP …
DURHAM, N.C., July 14, 2020 /PRNewswire/ -- Lamassu Pharma LLC, a privately held Biotech announced today it has received $1.5 million in Small Business Innovation …See details»
Lamassu Pharma Announces Development of New …
Apr 20, 2021 A new Mayo Clinic study led by Dr. Vijay Singh underscores the potential value of the lead therapeutic compound, RABI-767 in development by Lamassu Pharma, LLC, to treat acute pancreatitis.See details»
Lamassu Bio secures US NIH grant for sarcoma treatment
Mar 13, 2024 Lamassu Bio secures US NIH grant for sarcoma treatment. The company will carry out the trial in partnership with the Cleveland Clinic Taussig Cancer Center and …See details»
Lamassu Pharma Company Profile - Craft
Lamassu Pharma (formerly PreClinical Pathfinder) is a biotech company that provides clinical trials and therapeutics services. It offers critical unmet medical needs for severe …See details»
Lamassu Pharma Announces Development of New Pancreatitis …
DURHAM, N.C., April 20, 2021 /PRNewswire/ — Despite being known as “good” fat, excess unsaturated fatty acids may prove deadly for patients who develop, pancreatitis, COVID …See details»
Lamassu Pharma Announces Development of New ... - Markets …
Apr 20, 2021 Founded in 2018, Lamassu Pharma leverages innovative and insightful technology to drive collaboration between academia and industry through translational …See details»
Lamassu Pharma - Products, Competitors, Financials, Employees ...
Lamassu Pharma. Unclaimed. lamassupharma.com. Overview & Products. Financials. People. Founded Year. 2018. Stage. Grant | Alive. Total Raised. $4.72M. Last Raised. …See details»
Lamassu Pharma - Contacts, Employees, Board Members, …
Rabi Hanna CMO & Co-Founder. Greg Palmer CSO & Co-Founder. Unlock even more features with Crunchbase Pro. Start Your Free Trial. Lamassu Pharma is a biotech …See details»
Lamassu Pharma - Funding, Financials, Valuation & Investors
Lamassu Pharma has raised a total of. $4.7M. in funding over 2 rounds. Their latest funding was raised on Mar 12, 2024 from a Grant round. Lamassu Pharma is funded by 2 …See details»
Lamassu Pharma - Overview, News & Similar companies
Nov 3, 2021 Is Lamassu Pharma a public company? See more information about Lamassu Pharma. View Lamassu Pharma (www.lamassupharma.com) location in North Carolina, …See details»
Why Lamassu Pharma is developing a novel pancreatitis treatment
Aug 24, 2021 Lamassu Pharma (Durham, N.C.) is developing a drug known as RABI-767 that could offer hope to patients with severe acute pancreatitis. The company is gearing …See details»
Lamassu Pharma | CipherBio
Explore Lamassu Pharma's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»